In rapid succession, Infinity Pharmaceuticals Inc. announced its second and third collaborations, forming with two pharmaceutical companies agreements that include equity investments. (BioWorld Today)

PARIS - Neuro3d closed a third round of financing in which it raised €31.5 million (US$41.6 million) from eight European venture capital funds. (BioWorld International)